long intergenic non-protein coding RNA 707Genealiases: []
Q-omics provides the consensus-scored LINC00707 profile across patient tissues and cancer cell-line models. LINC00707 expression is associated with patient survival in 26 of 34 cancer types, with the highest sampling consensus in LUAD. Among the 18 cancer types available for tumor–normal comparison, LINC00707 is differentially expressed in 15, with the highest sampling consensus in HNSC. Additionally, LINC00707 RNA expression shows 11,998 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight LUAD, HNSC, and THYM as cancer lineages where LINC00707 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC00707 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC00707 survival associations across molecular data types. LINC00707 RNA expression shows survival associations in the most cancer types (26). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC00707 RNA expression–survival associations across cancer types. High LINC00707 expression shows unfavorable associations in LUAD, HNSC, LGG and KIRP, but favorable associations in SKCM and ESCA. The LUAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify LUAD as the clearest survival context for LINC00707 RNA expression.
This table summarizes LINC00707 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 15. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC00707. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC00707 shows lower tumor expression in UCEC and BRCA and higher tumor expression in HNSC, KIRC, LUAD and KIRP. The HNSC box plot shows higher LINC00707 RNA expression in tumor versus normal tissue (log2 FC = +2.725, t-test p < 0.001).
This table shows molecular features associated with LINC00707 in patient tissues and cancer cell lines. In patient samples, LINC00707 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
